Total Payments
$230.83
2024 Payments
$40.85
Companies
8
Transactions
12
Medicare Patients
679
Medicare Billing
$178,836
Payment Breakdown by Category
Food & Beverage$230.83 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $230.83 | 12 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $77.33 | 3 | $0 (2024) |
| PFIZER INC. | $42.06 | 3 | $0 (2020) |
| Allergan Inc. | $24.97 | 1 | $0 (2018) |
| United Therapeutics Corporation | $24.95 | 1 | $0 (2018) |
| Gilead Sciences, Inc. | $24.18 | 1 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $13.27 | 1 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $13.00 | 1 | $0 (2018) |
| CSL Behring | $11.07 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $40.85 | 2 | Gilead Sciences, Inc. ($24.18) |
| 2023 | $60.66 | 2 | Janssen Pharmaceuticals, Inc ($60.66) |
| 2020 | $13.08 | 1 | PFIZER INC. ($13.08) |
| 2019 | $11.07 | 1 | CSL Behring ($11.07) |
| 2018 | $62.92 | 3 | Allergan Inc. ($24.97) |
| 2017 | $42.25 | 3 | PFIZER INC. ($28.98) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/10/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/28/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.18 | General |
| 11/22/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $28.10 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/18/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $32.56 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/14/2020 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/26/2019 | CSL Behring | Kcentra (Biological) | Food and Beverage | Cash or cash equivalent | $11.07 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 08/02/2018 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/19/2018 | Merck Sharp & Dohme Corporation | NOXAFIL (Drug), PREVYMIS, DIFICID | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/18/2018 | United Therapeutics Corporation | ORENITRAM (Drug) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: PAH | ||||||
| 08/02/2017 | PFIZER INC. | PRECEDEX (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: SEDATIVE | ||||||
| 06/15/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.27 | General |
| Category: Cardiovascular | ||||||
| 04/25/2017 | PFIZER INC. | ELIQUIS (Drug), CHANTIX | Food and Beverage | In-kind items and services | $10.83 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 77 | 308 | $95,479 | $39,343 |
| 2022 | 7 | 154 | 323 | $79,339 | $31,619 |
| 2021 | 8 | 259 | 541 | $123,880 | $53,005 |
| 2020 | 5 | 189 | 475 | $121,917 | $54,869 |
Total Patients
679
Total Services
1,647
Medicare Billing
$178,836
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 21 | 119 | $62,114 | $20,248 | 32.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 31 | 164 | $26,240 | $15,629 | 59.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 25 | 25 | $7,125 | $3,467 | 48.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 36 | 145 | $23,614 | $11,714 | 49.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 22 | 56 | $30,018 | $9,631 | 32.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 28 | 30 | $8,550 | $4,551 | 53.2% |
| G0407 | Follow-up inpatient consultation, intermediate, physicians typically spend 25 minutes communicating with the patient via telehealth | Office | 2022 | 25 | 34 | $5,846 | $1,730 | 29.6% |
| G0408 | Follow-up inpatient consultation, complex, physicians typically spend 35 minutes communicating with the patient via telehealth | Office | 2022 | 14 | 18 | $4,462 | $1,419 | 31.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 12 | 23 | $2,806 | $1,293 | 46.1% |
| G0425 | Telehealth consultation, emergency department or initial inpatient, typically 30 minutes communicating with the patient via telehealth | Office | 2022 | 17 | 17 | $4,043 | $1,281 | 31.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 53 | 238 | $38,476 | $19,692 | 51.2% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 33 | 87 | $45,240 | $15,262 | 33.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 47 | 47 | $13,395 | $7,350 | 54.9% |
| G0508 | Telehealth consultation, critical care, initial , physicians typically spend 60 minutes communicating with the patient and providers via telehealth | Office | 2021 | 14 | 14 | $6,006 | $2,463 | 41.0% |
| G0425 | Telehealth consultation, emergency department or initial inpatient, typically 30 minutes communicating with the patient via telehealth | Office | 2021 | 28 | 29 | $6,235 | $2,365 | 37.9% |
| G0407 | Follow-up inpatient consultation, intermediate, physicians typically spend 25 minutes communicating with the patient via telehealth | Office | 2021 | 27 | 39 | $6,084 | $2,281 | 37.5% |
| G0406 | Follow-up inpatient consultation, limited, physicians typically spend 15 minutes communicating with the patient via telehealth | Office | 2021 | 44 | 61 | $5,124 | $1,907 | 37.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Office | 2021 | 13 | 26 | $3,320 | $1,685 | 50.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 61 | 288 | $46,080 | $24,219 | 52.6% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 37 | 93 | $48,360 | $16,627 | 34.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 58 | 60 | $17,100 | $9,827 | 57.5% |
| G0508 | Telehealth consultation, critical care, initial , physicians typically spend 60 minutes communicating with the patient and providers via telehealth | Office | 2020 | 20 | 20 | $8,641 | $3,380 | 39.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Office | 2020 | 13 | 14 | $1,736 | $815.35 | 47.0% |
About Dr. Robert Baird, M.D
Dr. Robert Baird, M.D is a Critical Care Medicine healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1942259163.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Baird, M.D has received a total of $230.83 in payments from pharmaceutical and medical device companies, with $40.85 received in 2024. These payments were reported across 12 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($230.83).
As a Medicare-enrolled provider, Baird has provided services to 679 Medicare beneficiaries, totaling 1,647 services with total Medicare billing of $178,836. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease
- Location Dallas, TX
- Active Since 05/06/2006
- Last Updated 03/14/2023
- Taxonomy Code 207RC0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1942259163
Products in Payments
- XARELTO (Drug) $77.33
- ELIQUIS (Drug) $37.18
- AVYCAZ (Drug) $24.97
- ORENITRAM (Drug) $24.95
- PRECEDEX (Drug) $18.15
- NOXAFIL (Drug) $13.00
- Kcentra (Biological) $11.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Dallas
Dr. Yolanda Mageto, Md, MD
Critical Care Medicine — Payments: $248,495
Critical Care Medicine $248,495
Sonja Bartolome, M.d, M.D
Critical Care Medicine — Payments: $194,111
Critical Care Medicine $194,111
Corey Kershaw, Md, MD
Critical Care Medicine — Payments: $116,660
Critical Care Medicine $116,660
Dr. Jagadeshwar Reddy, M.d, M.D
Critical Care Medicine — Payments: $10,977
Critical Care Medicine $10,977
Mr. Humayun Anjum, M.d, M.D
Critical Care Medicine — Payments: $10,184
Critical Care Medicine $10,184
Todd Grazia, Md, MD
Critical Care Medicine — Payments: $8,074
Critical Care Medicine $8,074